Therefore, we attempted to construct a PD-1/PD-L1 signal inverter using NK92 cells to reverse the inhibitory signals from PD-L1 in pancreatic cancer cells to activation signals with strong targeted cytotoxicity toward PD-L1 positive tumor cells. This evidence concerns the gene PDCD1 and pancreatic neoplasm.